Last €19.63 EUR
Change Today -0.238 / -1.20%
Volume 0.0
WX8 On Other Exchanges
Symbol
Exchange
New York
As of 2:07 AM 03/3/15 All times are local (Market data is delayed by at least 15 minutes).

biomed realty trust inc (WX8) Snapshot

Open
€19.63
Previous Close
€19.87
Day High
€19.63
Day Low
€19.63
52 Week High
01/28/15 - €21.96
52 Week Low
03/27/14 - €13.90
Market Cap
4.0B
Average Volume 10 Days
10.0
EPS TTM
--
Shares Outstanding
203.7M
EX-Date
12/29/14
P/E TM
--
Dividend
€0.96
Dividend Yield
5.20%
Current Stock Chart for BIOMED REALTY TRUST INC (WX8)

Related News

No related news articles were found.

biomed realty trust inc (WX8) Related Businessweek News

No Related Businessweek News Found

biomed realty trust inc (WX8) Details

BioMed Realty Trust, Inc. operates as a real estate investment trust (REIT) that focuses on providing real estate to the life science industry in the United States. Its tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies, and other entities involved in the life science industry. The company owns or has interests in 72 properties, representing 119 buildings with approximately 11.0 million rentable square feet. Its properties are located predominantly in the major U.S. life science markets of Boston, San Diego, San Francisco, Seattle, Maryland, Pennsylvania, and New York/New Jersey. The company qualifies as a REIT for federal income tax purposes. It would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. BioMed Realty Trust was founded in 2004 and is based in San Diego, California.

247 Employees
Last Reported Date: 02/6/15
Founded in 2004

biomed realty trust inc (WX8) Top Compensated Officers

Co-Founder, Chairman and Chief Executive Offi...
Total Annual Compensation: $760.0K
Co-Founder, Executive Vice President and Dire...
Total Annual Compensation: $125.0K
Chief Financial Officer
Total Annual Compensation: $420.0K
Compensation as of Fiscal Year 2013.

biomed realty trust inc (WX8) Key Developments

BioMed Realty Trust Inc. Announces Executive Changes

BioMed Realty Trust Inc. announced a realignment, including a number of promotions and additions to its leadership team. The company announced that, effective February 25, 2015, Kent Griffin is leaving his role as President and Chief Operating Officer to pursue other business opportunities. The company's executive bench is strengthened with the promotion of John Bonanno to Executive Vice President of Leasing & Development and Jon Klassen to Executive Vice President and General Counsel.

BioMed Realty Trust Inc. Breaks Ground on i3, a New 316,000 Square Foot Iconic Development in San Diego

BioMed Realty Trust Inc. broke ground on a new 316,000 square foot laboratory and office campus designed to meet the unique real estate needs of San Diego's thriving life science industry. i3 is centered in the scenic and dynamic University Town Centre area of the city. The iconic i3 campus will bring together the key elements needed by life science companies and their employees. For life science companies to thrive, grow and conduct great research they require an environment with flexible design, great amenities and easy access to transportation. Along with a 16,000 square foot amenities area, the campus will have three 100,000 square foot fully customizable buildings with adaptable lab zones enabling companies to more effectively create the environments of innovation unique to their science. The campus will create an atmosphere of connectivity, innovation and collaboration with outdoor conferencing and auditorium, an open courtyard programmed with activities for employees, modern fitness center and a unique market and cafe. BioMed Realty estimates life science real estate in San Diego to be approximately 94% occupied, leaving fewer options for new companies to start and existing companies to grow and expand. Also, with the 316,000 square feet at i3, BioMed Realty will now have 18 million rentable square feet with eight development projects underway adding nearly two million square feet under construction in such places as Cambridge, the San Francisco Bay Area, New York, the United Kingdom, Seattle and Winston-Salem.

BioMed Realty Trust Inc. Declares Special Dividend; Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2014; Provides Earnings Guidance for the Year 2015

BioMed Realty Trust Inc.'s board of directors declared a special dividend of $0.30 per share of common stock reflecting a return to stockholders of a portion of the proceeds from the sale of the 9911 Belward Campus Drive property. For the full year 2014, the company declared dividends totaling $1.31 per common share, representing a 37.2% total increase over common stock dividends declared in 2013, including the special dividend. The company reported unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2014. For the quarter, the company's total revenues were $165,656,000 compared to $157,993,000 a year ago. Income from operations was $29,966,000 compared to $37,485,000 a year ago. Net income was $144,627,000 compared to $10,576,000 a year ago. Net income attributable to the company was $140,349,000 compared to $10,279,000 a year ago. Net income available to common stockholders was $140,349,000 or $0.70 per diluted share compared to $10,279,000 or $0.05 per diluted share a year ago. Income from continuing operations per diluted share available to common stockholders was $0.70 compared to $0.05 a year ago. FFO available to common shares and units - diluted was $73,157,000 or $0.35 per diluted share compared to $70,997,000 or $0.34 per diluted share a year ago. CFFO available to common shares and units - diluted was $74,117,000 or $0.36 per diluted share compared to $71,016,000 or $0.34 per diluted share a year ago. AFFO available to common shares and units diluted was $56,732,000 or $0.27 per diluted share compared to $65,395,000 or $0.31 per diluted share a year ago. For the year, the company's total revenues were $674,609,000 compared to $637,314,000 a year ago. Income from operations was $148,240,000 compared to $158,784,000 a year ago. Net income was $201,468,000 compared to $47,209,000 a year ago. Net income attributable to the company was $193,778,000 compared to $46,644,000 a year ago. Net income available to common stockholders was $193,778,000 or $0.98 per diluted share compared to $37,720,000 or $0.20 per basic and diluted share a year ago. Income from continuing operations per diluted share available to common stockholders was $0.98 compared to $0.20 a year ago. FFO available to common shares and units - diluted was $323,612,000 or $1.55 per diluted share compared to $290,429,000 or $1.47 per diluted share a year ago. CFFO available to common shares and units - diluted was $327,443,000 or $1.57 per diluted share compared to $295,711,000 or $1.49 per diluted share a year ago. AFFO available to common shares and units was $276,623,000 or $1.32 per diluted share compared to $281,488,000 or $1.42 per diluted share a year ago. The company also projected net income per diluted share available to common stockholders to be in the range of $0.15 to $0.25. Projected FFO and CFFO per diluted share in the range of $1.39 to $1.49. The company raised the midpoint of FFO guidance for 2015 to $1.44 per diluted share.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
WX8:GR €19.63 EUR -0.238

WX8 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
American Campus Communities Inc $41.44 USD +0.17
Camden Property Trust $73.12 USD +0.33
Douglas Emmett Inc $28.78 USD -0.09
Equity LifeStyle Properties Inc $54.45 USD +0.58
Home Properties Inc $67.44 USD +0.67
View Industry Companies
 

Industry Analysis

WX8

Industry Average

Valuation WX8 Industry Range
Price/Earnings 24.0x
Price/Sales 6.7x
Price/Book 1.5x
Price/Cash Flow 10.1x
TEV/Sales 2.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOMED REALTY TRUST INC, please visit www.biomedrealty.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.